People with type 2 diabetes are at increased risk of developing other health problems such as heart disease and stroke. The GLoW study is trying to find out the best way to help people with type 2 diabetes to lower their blood glucose, improve their health and reduce their risk of developing other health problems.
What treatments are we looking at?
The GLoW trial will evaluate two programmes which have been shown to support people with type 2 diabetes to improve their diet and physical activity and improve their health. The first programme is a diabetes education programme called DESMOND, which involves attending a one day group diabetes education session in person or completing the alternative online course called MyDESMOND. The second is a diabetes education and weight management programme called “Live Well With Diabetes”. This involves diabetes education from a registered dietitian over the phone and free attendance at weekly WW (formerly Weight Watchers) meetings for 6 months.
What are we hoping to find out?
We want to compare the two programmes and see which one has the best impact on health and wellbeing and which one offers the best value for money for the NHS.
How will we do this?
We will do this by running a research study (called a trial). We will recruit participants and randomly assign them into one of two groups: one group receives DESMOND; and one group receives Live Well With Diabetes. Participants will attend appointments appointments or be sent measurement packs to be completed at home at the start of the study, and again at 6 months and 12 months, so we can measure changes in their blood glucose and other health outcomes, as well as changes in their diet and physical activity.
Who can take part?
We are currently recruiting adults (aged over 18 years) resident in the UK who have been diagnosed with type 2 diabetes in the last 3 years and have not yet completed a diabetes education programme. If this sounds like you and you are interested in taking part, you can read the Participant Information Sheet below and complete the online screening and consent form.
If you have any questions please contact the study team at GLOW.email@example.com.